(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYTOTUNE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYTOTUNE

ST13

US500000079089375

Class

1, 5, 42

Filing

79089375

Registration

4095058

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

64

Latest update

05/04/2025

Trademark type

Word

Nice classes

1, 5, 42

Filing date

07/02/2010

Registration date

02/07/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/13/2022

Last transaction

05/04/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Tsukuba-shi Ibaraki, JP

Examiner

DE JONGE, KATHLEEN

Law office

L70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

ID Pharma Co., Ltd.
D. C. (pessoa física)

Representatives

Stacey R. Halpern KNOBBE MARTENS OLSON & BEAR LLP

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicalspolypeptides for in vitro and in vivo scientific and research use; biochemicalspolynucleotides for in vitro and in vivo scientific and research use ; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific researchreagentscosmeticspharmaceuticals

Class 5

Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancercritical limb ischemiacystic fibrosisretinitis pigmentosaAIDSinfluenzaAlzheimer's disease; preparations for gene therapyintroducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical usefor gene therapy

Class 42

Testinginspectionresearchdevelopment of pharmaceuticalscosmeticsfoodstuff; testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; testinginspectionresearchdevelopment of vaccines; testinginspectionresearchdevelopment of recombinant proteins; medicalchemicalbiochemicalbiological and bacteriological research and functional analysis of genes or proteins; testinginspectionresearch related to technologies for manufacturing genetically engineered animalsplantsvectors; testinginspectionresearchdevelopment of vector technologiesmedical and scientific research in the field of genetics and genetic engineering; testinginspectionresearch on agriculturelivestock breedingfisheries; testinginspectionresearchdevelopment of chemicals for life science

Publications

History of USPTO decisions and trademark events.

64 publications found

Further Decision Processed by IB

05/03/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/07/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

03/07/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

03/07/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/13/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/13/2022

71AG

REGISTERED-SEC.71 ACCEPTED

07/13/2022

ES71

TEAS SECTION 71 RECEIVED

07/11/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

02/07/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/14/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/06/2019

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

05/10/2019

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/19/2019

INPC

INVALIDATION PROCESSED

03/19/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/13/2019

RFNP

REFUSAL PROCESSED BY IB

01/05/2019

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

07/13/2018

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

07/13/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/13/2018

ES75

TEAS SECTION 71 & 15 RECEIVED

06/18/2018

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/07/2017

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/01/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/28/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/06/2012

FIMP

FINAL DISPOSITION PROCESSED

07/06/2012

GPNX

NOTIFICATION PROCESSED BY IB

06/30/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/07/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

02/07/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/22/2011

PUBO

PUBLISHED FOR OPPOSITION

11/22/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/03/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/02/2011

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/02/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/18/2011

ATRV

ATTORNEY REVIEW COMPLETED

10/18/2011

LIMS

LIMITATION OF GOODS/SERVICES FROM IB ENTERED

10/17/2011

ALIE

ASSIGNED TO LIE

10/13/2011

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

10/08/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/23/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/22/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/21/2011

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/21/2011

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

09/07/2011

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

09/02/2011

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

06/01/2011

GNSF

SUBSEQUENT FINAL EMAILED

06/01/2011

CFRC

SUBSEQUENT FINAL REFUSAL WRITTEN

06/01/2011

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/01/2011

GNFR

FINAL REFUSAL E-MAILED

06/01/2011

CNFR

FINAL REFUSAL WRITTEN

06/01/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/25/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/25/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/25/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/06/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/06/2011

RFNT

REFUSAL PROCESSED BY IB

12/18/2010

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/30/2010

RFRR

REFUSAL PROCESSED BY MPU

11/30/2010

MAFR

APPLICATION FILING RECEIPT MAILED

11/30/2010

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/29/2010

CNRT

NON-FINAL ACTION WRITTEN

11/28/2010

DOCK

ASSIGNED TO EXAMINER

11/26/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/26/2010

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/25/2010

Continuous trademark protection

Get notified about every new filing that threatens CYTOTUNE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.